awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33437948-31C5AE7B-F0E5-4964-855C-2618C51C27EC
Q33437948-31C5AE7B-F0E5-4964-855C-2618C51C27EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33437948-31C5AE7B-F0E5-4964-855C-2618C51C27EC
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors.
P2860
Q33437948-31C5AE7B-F0E5-4964-855C-2618C51C27EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33437948-31C5AE7B-F0E5-4964-855C-2618C51C27EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e489fcdb5af08f3614340b41d6663d274f3deff9
P2860
Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.